Intestinal cancer test kit B052T050B0C2

for gastrointestinal diseasesfor furazolidonefor genes

Clarithromycin, Quinolone-Resistant and Non-Resistant Helicobacter Pylori Nucleic Acid Amplification Test Kit Predicator of Gastric Cancer This kit is intended for use in the qualitative detection of Helicobacter pylori (H. pylori) nucleic acid DNA and mutation sites related to Clarithromycin and Quinolones resistance from human gastric mucosal biopsy specimens. Helicobacter pylori infection is a common worldwide infection, and about 50% of the world's population were infected with H. pylori. H. pylori is an important cause of gastrointestinal digestive system-related diseases, such as chronic gastritis, stomach ulcers, duodenum ulcers, and gastric cancer, etc. Currently, the treatment regimen for H. pylori in clinical is triple or quadruple therapy consisting of antibiotics and PPI. The overuse and misuse of antibiotics have led to H. pylori resistance to antibiotics; therefore, the detection of H. pylori and its resistance is important for guiding of clinical treatments of H. pylori Infection.